Metastatic Hormone-Sensitive Prostate Cancer: The Role of Docetaxel in Triple-Therapy Regimens. (2025). Voprosy Onkologii, 71(4), OF-2167. https://doi.org/10.37469/0507-3758-2025-71-4-OF-2167